PubMedopen access
AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review (2020-present).
humans, patents as topic, aldo-keto reductase family 1 member c3, animals, antineoplastic agents, drug resistance, neoplasm
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 425505
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.